Editorial board

Stephen P. Jenkins London School of Economics and Political Science, UK
Nicholas J. Cox Durham University, UK

Christopher F. Baum Boston College, USA
Nathaniel Beck New York University, USA
Rino Bellocco Karolinska Institutet, Sweden, and University of Milano-Bicocca, Italy
Maarten L. Buis University of Konstanz, Germany
A. Colin Cameron University of California, Davis, USA
Mario A. Cleves University of South Florida, USA
Michael Crowther Red Door Analytics, Sweden
David M. Drukker Clemson University, USA
William D. Dupont Vanderbilt University, USA
James Hardin University of South Carolina, USA
Ben Jann University of Bern, Switzerland
Ulrich Kohler University of Potsdam, Germany
Frauke Kreuter University of Maryland, College Park, USA
Stanley Lemeshow Ohio State University, USA
J. Scott Long Indiana University, USA
Roger Newson Queen Mary University, London, UK
Austin Nichols Amazon, Washington, DC, USA
Marcello Pagano Harvard School of Public Health, USA
Sophia Rabe-Hesketh University of California - Berkeley, USA
J. Patrick Royston MRC CTU at UCL, London, UK
Mark E. Schaffer Heriot-Watt University, Edinburgh, UK
Clyde Schechter Albert Einstein College of Medicine, USA
Philippe Van Kerm Luxembourg Institute of Socio-Economic Research, Luxembourg
Vincenzo Verardi Université Catholique de Louvain, Belgium
Ian White MRC Clinical Trials Unit at UCL, UK
Richard A. Williams University of Notre Dame, USA
Jeffrey M. Wooldridge Michigan State University, USA